Proud Moment: HealthOrbit AI Co-Founder Rakesh Kaipenchery to Attend Cure by Deerfield Cohort in New York (11–13 Nov 2025)

We’re beyond proud to announce that HealthOrbit AI and our visionary Co-Founder, Rakesh Kaipenchery, have been selected among an elite group of 15 startups from around the world to join the first-ever Cure by Deerfield Middle East Health Accelerator — a prestigious program empowering innovators who are shaping the future of global healthcare.
Read the official announcement on PR Newswire 

This recognition marks a momentous milestone in our mission to transform healthcare through AI-driven intelligence, compassion, and innovation. 

We’re honoured that Rakesh Kaipenchery will represent HealthOrbit AI at the accelerator’s launch event in New York City, from November 11 to 13, 2025, joining global visionaries, healthcare leaders, and changemakers who share a singular purpose — to advance human health through collaboration and breakthrough technology.  

“This moment is both humbling and energising. It reinforces our belief that technology can truly humanise healthcare and touch lives worldwide,” said Rakesh Kaipenchery, Co-Founder of HealthOrbit AI. 

Through the program, HealthOrbit AI will gain world-class mentorship, strategic global exposure, and access to innovation networks — accelerating our drive to empower healthcare professionals and improve patient outcomes across the world. 

This isn’t just a proud moment for us — it’s a testament to what belief, persistence, and purpose can create when guided by vision. 

To our incredible team, partners, and supporters: thank you for believing in our orbit and propelling us forward. The journey continues — and it’s headed to new heights. Together, we’re redefining the future of care.
Read the full update on LinkedIn

Have any Question?

Become a part of our growing community of healthcare professionals and technology enthusiasts.

Recent Articles

Frequently Asked Questions

1- When will I get my EIS3 certificate and when are the shares issued?

Shares are usually issued within two weeks of completing your investment. You’ll get your EIS3 certificate 2–4 months later, once HMRC processes it. This is what you’ll need to claim your tax relief.

You must hold your shares for at least three years from the date they were issued (or when the company started trading, whichever is later). Selling early could mean losing your tax relief.

You may exit if the company is acquired, lists on a stock exchange, or arranges a buyback or sale to other investors. Most exits happen after three years to keep the EIS tax benefits.

We’ll send regular updates—usually every quarter or six months—about company progress. You can also contact us anytime. We believe in open, transparent communication with our investors.

As with all early-stage investments, there’s a risk of losing money. But EIS helps reduce that risk:
✔️ 30% income tax relief
✔️ Loss relief if things don’t work out
✔️ Tax-free growth on exit

Book a Demo
Healtorbit logo

Ready to Try HealthOrbit?

Jump Right In

Skip the Demo, Sign Up Instantly!

Comfortable with AI scribe

Take a Tour

Take a Tour: HealthOrbit AI Scribe in Action

New to AI scribe

Book A demo

Talk to Our Customer Success Experts

Perfect of Enterprise

Healtorbit logo

Schedule a Demo